Trials / Unknown
UnknownNCT03943420
One Research on Improving Cognitive Impairment Caused by Hypertension
One Research on Application of Key Technologies About Improving Cognitive Impairment Caused by Hypertension With the Therapy of Early Intervention With Qianyang Yuyin Granules
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 144 (estimated)
- Sponsor
- Jiangsu Famous Medical Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 55 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Using the therapy of early intervention with Qianyang Yuyin Granules to improve cognitive impairment caused by hypertension.
Detailed description
Using the therapy of early intervention with Qianyang Yuyin Granules to improve cognitive impairment caused by hypertension. The investigators designed a multi-center randomized controlled clinical trial to study the security and effectiveness of this therapy.
Conditions
Timeline
- Start date
- 2018-12-28
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2019-05-09
- Last updated
- 2019-05-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03943420. Inclusion in this directory is not an endorsement.